| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 3.38 mm | 3.38 mm | 3.38 mm | 3.38 mm | 3.38 mm | 3.38 mm |
| Cash burn (monthly) | 88.94 k | (no burn) | 1.47 mm | 777.64 k | 919.53 k | 886.03 k |
| Cash used (since last report) | 452.09 k | n/a | 7.46 mm | 3.95 mm | 4.67 mm | 4.50 mm |
| Cash remaining | 2.93 mm | n/a | -4.08 mm | -572.59 k | -1.29 mm | -1.12 mm |
| Runway (months of cash) | 32.9 | n/a | -2.8 | -0.7 | -1.4 | -1.3 |
| 13F holders | Current |
|---|---|
| Total holders | 30 |
| Opened positions | 15 |
| Closed positions | 14 |
| Increased positions | 0 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 36.92 mm |
| Total shares | 25.59 mm |
| Total puts | 0.00 |
| Total calls | 108.75 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Atwood Brian G | 19.61 mm | $1.51 mm |
| Phoenix Biotech Sponsor | 1.00 mm | $2.24 mm |
| Stuart M Sloan | 996.67 k | $2.23 mm |
| Fitzgerald Securities Cantor | 905.00 k | $8.97 mm |
| Cantor Fitzgerald, L. P. | 441.05 k | $4.10 mm |
| MMCAP International Inc. SPC | 375.00 k | $3.11 mm |
| Saba Capital Management | 295.91 k | $2.71 mm |
| Periscope Capital | 274.00 k | $2.27 mm |
| Clear Street Derivatives | 268.13 k | $2.00 k |
| Linden Advisors | 250.00 k | $2.30 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Feb 25 | Atwood Brian G | Stock Option Common Stock | Grant | Acquire A | No | No | 0.1 | 254,000 | 25.40 k | 508,000 |
| 24 Feb 25 | Michael Byrnes | Stock Option Common Stock | Grant | Acquire A | No | No | 0.1 | 127,500 | 12.75 k | 255,000 |
| 24 Feb 25 | Christopher B Ehrlich | Stock Option Common Stock | Grant | Acquire A | No | No | 0.1 | 1,275,000 | 127.50 k | 2,550,000 |
| 24 Feb 25 | Laporte Kathleen | Stock Option Common Stock | Grant | Acquire A | No | No | 0.1 | 127,500 | 12.75 k | 255,000 |
| 24 Feb 25 | Shami Patel | Stock Option Common Stock | Grant | Acquire A | No | No | 0.0951 | 127,500 | 12.13 k | 255,000 |
